22 Oct 2018 | 8:50 PM
 

Alembic Pharmaceuticals Ltd. Share Price Live (BSE)
0

BSE Code: 533573 | NSE Symbol: APLLTD
580.05
-28.05
(-4.61 %)
22 Oct 2018 | 03:44 PM
Change company
  • Open (Rs)
    619.35
  • Prev. close (Rs.)
    608.10
  • High (Rs.)
    623.50
  • Low (Rs.)
    571.90
  • 52W H (Rs.)
    664.00
  • 52W L (Rs.)
    412.40
  • Volume
    53489
  • MCap (Rs in Cr.)
    10,934.88
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
21.89
Operating Margin (%)
20.56
Gross Profit Margin (%)
17.19
Net Profit Margin (%)
13.17
Total Debt/Equity
0.32
Dividend payout Ratio (Net Profit)
21.99
Earning Retention Ratio
78.47

News

22 Oct 2018 - 15:12:00-Alembic Pharmaceuticals Monday reported 64.58 per cent rise in consolidated net profit to Rs 200...
17 Sep 2018 - 14:20:00-Alembic Pharmaceuticals said it has received approval from the US health regulator to market Desenla...
10 Sep 2018 - 16:08:00-Alembic Pharmaceuticals Monday said its board has approved a proposal to raise up to Rs 300 crore th...
06 Aug 2018 - 12:10:00-Drug firm Alembic Pharmaceuticals has received tentative approval from the US Food and Drug Administ...

Announcements

22-Oct-2018
Alembic Pharmaceutic - Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September 2018.
22-Oct-2018
Alembic Pharmaceutic - Outcome of Board Meeting
22-Oct-2018
Alembic Pharmaceutic - Financial Result Updates
22-Oct-2018
Alembic Pharmaceutic - Press Release
22-Oct-2018
Alembic Pharmaceutic - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Religare Research

19 Oct 2018 | 07:00 PM
Nifty failed to cross the hurdle at 10,700 last week and ended with loss of nearly 1.5%, pressurized...
19 Oct 2018 | 06:00 PM
Nifty failed to cross resistance zone at 10,700 last week and slipped almost vertically thereafter. ...
19 Oct 2018 | 10:33 AM
• Gold edges higher as Asian shares slip • Oil prices edge up, but set for weekly loss on stock buil...
19 Oct 2018 | 10:18 AM
The rupee settled at 73.60 to a dollar, against 73.46 at previous close. The currency opened slightl...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
6,09,449 43.57 15.01 -0.60
6,09,449 43.57 32.97 -0.60
6,09,449 43.57 35.27 -0.59
6,09,449 43.57 19.08 -0.62
6,09,449 43.57 11.82 -0.59

Shareholding Pattern

       
Promotors72.96%
Mutual Funds/UTI5.14%
FI/Banks0.42%
Insurance0.42%
FII9.32%
Government0.00%
Others1.88%

Peer Group

Company Intraday Graph
 Abbott India Ltd.
7,228.60(-0.22)
3280
 Sanofi India Ltd.
5,826.00(-1.58)
3325
 Pfizer Ltd.
2,753.75(-1.93)
3370
 Dr. Reddy`s Laboratories Ltd.
2,521.35(-0.99)
3294

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Alembic Pharmaceuticals Ltd.-58.6049.1079.50
NIFTY(S&P CNX)-989.10-764.95-320.05
BSE SENSEX-2,986.84-2,361.99-292.91
BSE 500-1,536.18-1,132.47-1,225.89

Corporate Details

Key Personal
Chirayu Amin
Chairman & CEO
Pranav Amin
Managing Director
R K Baheti
Director - Finance & CFO
Key Address
Registered Office
Alembic Road,Vadodra,Gujarat

Tel:0265-2280550, Fax:0265-2282506

apl.investors@alembic.co.in
http://www.alembicpharmaceuticals.com
Registrar Office
Link Intime India Pvt. Ltd.
Add. :44 Community Center 2nd Floor Naraina Industrial Area Phase I Near PVR Naraina